These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9684942

  • 21. Effects of long-term administration of hypericum extracts on the affinity and density of the central serotonergic 5-HT1 A and 5-HT2 A receptors.
    Teufel-Mayer R, Gleitz J.
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():113-6. PubMed ID: 9342771
    [Abstract] [Full Text] [Related]

  • 22. St. John's wort.
    Med Lett Drugs Ther; 1997 Nov 21; 39(1014):107-8. PubMed ID: 9398822
    [No Abstract] [Full Text] [Related]

  • 23. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
    Obach RS.
    J Pharmacol Exp Ther; 2000 Jul 21; 294(1):88-95. PubMed ID: 10871299
    [Abstract] [Full Text] [Related]

  • 24. Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro.
    Capasso R, Borrelli F, Capasso F, Mascolo N, Izzo AA.
    Urology; 2004 Jul 21; 64(1):168-72. PubMed ID: 15245964
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of MAO by fractions and constituents of hypericum extract.
    Bladt S, Wagner H.
    J Geriatr Psychiatry Neurol; 1994 Oct 21; 7 Suppl 1():S57-9. PubMed ID: 7857511
    [Abstract] [Full Text] [Related]

  • 26. In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract.
    Cott JM.
    Pharmacopsychiatry; 1997 Sep 21; 30 Suppl 2():108-12. PubMed ID: 9342770
    [Abstract] [Full Text] [Related]

  • 27. Hypericum perforatum subspecies angustifolium shows a protective activity on the consequences of unavoidable stress exposure at lower doses than Hypericum perforatum perforatum.
    Usai M, Leggio B, Grappi S, Nanni G, Gambarana C, Tolu P, Giachetti D, De Montis MG.
    Pharmacopsychiatry; 2003 Nov 21; 36(6):283-7. PubMed ID: 14663651
    [Abstract] [Full Text] [Related]

  • 28. Interleukin-6 involvement in antidepressant action of Hypericum perforatum.
    Calapai G, Crupi A, Firenzuoli F, Inferrera G, Ciliberto G, Parisi A, De Sarro G, Caputi AP.
    Pharmacopsychiatry; 2001 Jul 21; 34 Suppl 1():S8-10. PubMed ID: 11518082
    [Abstract] [Full Text] [Related]

  • 29. Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1.
    Singer A, Wonnemann M, Müller WE.
    J Pharmacol Exp Ther; 1999 Sep 21; 290(3):1363-8. PubMed ID: 10454515
    [Abstract] [Full Text] [Related]

  • 30. In vivo neurotransmitter release in the locus coeruleus--effects of hyperforin, inescapable shock and fear.
    Philippu A.
    Pharmacopsychiatry; 2001 Jul 21; 34 Suppl 1():S111-5. PubMed ID: 11518058
    [Abstract] [Full Text] [Related]

  • 31. Hypericum extract and hyperforin: memory-enhancing properties in rodents.
    Klusa V, Germane S, Nöldner M, Chatterjee SS.
    Pharmacopsychiatry; 2001 Jul 21; 34 Suppl 1():S61-9. PubMed ID: 11518079
    [Abstract] [Full Text] [Related]

  • 32. Role of hyperforin in the pharmacological activities of St. John's Wort.
    Zanoli P.
    CNS Drug Rev; 2004 Jul 21; 10(3):203-18. PubMed ID: 15492771
    [Abstract] [Full Text] [Related]

  • 33. A study of the antidepressant activity of Hypericum perforatum on animal models.
    Gambarana C, Tolu PL, Masi F, Rinaldi M, Giachetti D, Morazzoni P, De Montis MG.
    Pharmacopsychiatry; 2001 Jul 21; 34 Suppl 1():S42-4. PubMed ID: 11518074
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort.
    Wonnemann M, Singer A, Siebert B, Müller WE.
    Pharmacopsychiatry; 2001 Jul 21; 34 Suppl 1():S148-51. PubMed ID: 11518066
    [Abstract] [Full Text] [Related]

  • 35. Effects of hypericum extract on the expression of serotonin receptors.
    Müller WE, Rossol R.
    J Geriatr Psychiatry Neurol; 1994 Oct 21; 7 Suppl 1():S63-4. PubMed ID: 7857514
    [Abstract] [Full Text] [Related]

  • 36. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of Hypericum perforatum on alcohol intake in rats.
    Perfumi M, Panocka I, Ciccocioppo R, Vitali D, Froldi R, Massi M.
    Alcohol Alcohol; 2001 Oct 21; 36(3):199-206. PubMed ID: 11373255
    [Abstract] [Full Text] [Related]

  • 37. Researching the antidepressant actions of Hypericum perforatum (St. John's wort) in animals and man.
    Franklin M, Cowen PJ.
    Pharmacopsychiatry; 2001 Jul 21; 34 Suppl 1():S29-37. PubMed ID: 11518072
    [Abstract] [Full Text] [Related]

  • 38. Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity.
    Müller WE, Rolli M, Schäfer C, Hafner U.
    Pharmacopsychiatry; 1997 Sep 21; 30 Suppl 2():102-7. PubMed ID: 9342769
    [Abstract] [Full Text] [Related]

  • 39. Herbal healers.
    McIntyre RV.
    J Okla State Med Assoc; 1998 Aug 21; 91(5):271. PubMed ID: 9714967
    [No Abstract] [Full Text] [Related]

  • 40. The antidepressant mechanism of Hypericum perforatum.
    Mennini T, Gobbi M.
    Life Sci; 2004 Jul 16; 75(9):1021-7. PubMed ID: 15207650
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.